Ultragenyx Pharmaceutical Inc. buy Evercore ISI
Start price
06.06.23
/
50%
€48.20
Target price
06.06.24
€74.95
Performance (%)
-20.33%
End price
07.06.24
€38.40
Summary
This prediction ended on 07.06.24 with a price of €38.40. The price of Ultragenyx Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.33%. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.282% | -1.282% | -29.032% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Evercore_ISI for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $80.00 price target on the stock, up previously from $60.00.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten